Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sodium Barbital
2. 144-02-5
3. Sodium 5,5-diethylbarbiturate
4. Barbitone Sodium
5. Veronal Sodium
6. Sodium Barbitone
7. Barbital, Sodium
8. 5,5-diethylbarbituric Acid Sodium Salt
9. Sodium 5,5-diethyl-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-olate
10. Sodium;5,5-diethyl-4,6-dioxo-1h-pyrimidin-2-olate
11. Embinal
12. Natrinal
13. Nervoseton
14. Soprinal
15. Thyalone
16. Sodium Veronal
17. Barbital Soluble
18. Soluble Barbital
19. Barbital Na
20. Barbitalum-natrium
21. Sodium Malonylurea
22. Sodium Ethylbarbital
23. Sodium Derivative Of 5,5-diethylbarbituric Acid
24. Barbital Sodico
25. Diethylmalonylurea Sodium
26. Natriumbarbitals
27. Sodium Diethylbarbiturate
28. Barbital Sodique
29. Barbitale Sodico
30. Natriumbarbitals [german]
31. Barbitale Sodico [dcit]
32. Diethylbarbiturate Monosodium
33. Barbitalum Natricum
34. 275l5m93qs
35. Barbital Sodico [inn-spanish]
36. Barbital Sodique [inn-french]
37. Ccris 3065
38. Barbitalum Natricum [inn-latin]
39. Barbital, Sodium Deriv.
40. Barbitone, Sodium Deriv.
41. Einecs 205-613-9
42. Barbital Sodium [inn:nf]
43. Unii-275l5m93qs
44. Ai3-02728
45. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-diethyl-, Monosodium Salt
46. 5,5-diethylbarbituric Acid Sodium Deriv.
47. Dsstox_cid_128
48. Dsstox_rid_75387
49. Dsstox_gsid_20128
50. Schembl236588
51. Barbituric Acid, 5,5-diethyl-, Sodium Salt
52. Dtxsid3020128
53. Bcp17724
54. Tox21_200862
55. Akos005111158
56. Akos015914161
57. Ncgc00258416-01
58. Cas-144-02-5
59. 5,5-diethylbarbituric Acid Salt Sodium Salt
60. B0002
61. S-4460
62. Q4078035
63. Sodium 5,5-diethylbarbiturate, Purum, >=99.0% (nt)
64. Sodium 5,5-diethylbarbiturate, Bioultra, >=99.0% (nt)
65. Sodium 5,5-diethylbarbiturate, Puriss. P.a., >=99.0% (nt)
66. Sodium 5,5-diethylbarbiturate, Saj Special Grade, >=98.0%
| Molecular Weight | 206.17 g/mol |
|---|---|
| Molecular Formula | C8H11N2NaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 206.06673650 g/mol |
| Monoisotopic Mass | 206.06673650 g/mol |
| Topological Polar Surface Area | 81.6 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 284 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Barbital Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Barbital Sodium, including repackagers and relabelers. The FDA regulates Barbital Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Barbital Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Barbital Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Barbital Sodium supplier is an individual or a company that provides Barbital Sodium active pharmaceutical ingredient (API) or Barbital Sodium finished formulations upon request. The Barbital Sodium suppliers may include Barbital Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Barbital Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Barbital Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Barbital Sodium active pharmaceutical ingredient (API) in detail. Different forms of Barbital Sodium DMFs exist exist since differing nations have different regulations, such as Barbital Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Barbital Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Barbital Sodium USDMF includes data on Barbital Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Barbital Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Barbital Sodium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Barbital Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Barbital Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Barbital Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Barbital Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Barbital Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Barbital Sodium suppliers with NDC on PharmaCompass.
Barbital Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Barbital Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Barbital Sodium GMP manufacturer or Barbital Sodium GMP API supplier for your needs.
A Barbital Sodium CoA (Certificate of Analysis) is a formal document that attests to Barbital Sodium's compliance with Barbital Sodium specifications and serves as a tool for batch-level quality control.
Barbital Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Barbital Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Barbital Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Barbital Sodium EP), Barbital Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Barbital Sodium USP).
LOOKING FOR A SUPPLIER?
